Word

MEIRAGTX

Status

Registered

Status Code

700

Status Date

Tuesday, July 31, 2018

Serial Number

87304368

Registration Number

5527437

Registration Date

Tuesday, July 31, 2018

Mark Type

4000

Filing Date

Tuesday, January 17, 2017

Published for Opposition

Tuesday, May 15, 2018

Trademark Owner History

MeiraGTx Limited - Original Registrant

Classifications

40 Custom manufacture of human therapeutics, pharmaceuticals, biologicals and biopharmaceuticals

5 Pharmaceutical products for use in gene therapy; pharmaceutical and biological preparations for the treatment of neurological and neurodegerative diseases, ocular diseases and rare diseases, in the nature of rare kidney diseases, rare cardiovascular diseases, rare hepato-gastro-enterological diseases, rare immunodeficiencies, developmental defects, neuromuscular diseases, rare neurological diseases, rare cardiovascular diseases, rare lung diseases, rare bone diseases, rare sensory disorders, rare skin diseases, rare diseases of connective tissue, rare endocrine diseases, rare hereditary metabolic diseases, rare nonmalignant hematologic disorders; pharmaceutical preparations, namely, anti-infectives, anti-inflammatories, antibacterial pharmaceuticals, antibiotics, antifungal preparations, antivirals; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; dermatological pharmaceutical products; pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases

1 Chemical additives, namely, chemical auxiliary agents, carriers and substances for use in the manufacture of pharmaceutical preparations

42 Scientific research in the field of genetics, gene therapy and genetic engineering; Genetic testing for scientific research purposes; scientific advisory services relating to gene therapy research; Scientific, biological, pharmaceutical and medical research and services; laboratory research in the fields of genetics, drug development, biotechnology, microbiology and molecular biology; biochemical and biotechnological analysis and services

Trademark Events

Jul 31, 2023

Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

Jul 31, 2018

Registered-Principal Register

May 15, 2018

Official Gazette Publication Confirmation E-Mailed

May 15, 2018

Published For Opposition

Apr 25, 2018

Notification Of Notice Of Publication E-Mailed

Apr 12, 2018

Approved For Pub - Principal Register

Apr 9, 2018

Teas/Email Correspondence Entered

Apr 9, 2018

Correspondence Received In Law Office

Apr 5, 2018

Assigned To Lie

Mar 23, 2018

Teas Request For Reconsideration Received

Oct 25, 2017

Notification Of Final Refusal Emailed

Oct 25, 2017

Final Refusal E-Mailed

Oct 25, 2017

Final Refusal Written

Oct 6, 2017

Teas/Email Correspondence Entered

Oct 5, 2017

Correspondence Received In Law Office

Oct 5, 2017

Teas Response To Office Action Received

Apr 12, 2017

Notification Of Non-Final Action E-Mailed

Apr 12, 2017

Non-Final Action E-Mailed

Apr 12, 2017

Non-Final Action Written

Apr 12, 2017

Assigned To Examiner

Jan 25, 2017

New Application Office Supplied Data Entered

Jan 20, 2017

New Application Entered